Intranasal delivery of stem cells as therapy for central nervous system disease
- 1 April 2015
- journal article
- review article
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 98 (2) , 145-151
Abstract
No abstract availableKeywords
Funding Information
- Department of Science and Technology, Shanxi Province of China (2013081058)
- Shanxi University of traditional Chinese Medicine (2011PY-1)
- Shanxi Scholarship Council of China (2014–7)
- Natural Science Foundation of Shanxi (2012021034-2)
- National Institutes of Health (1 R01NS075260)
- Mary Groff Foundation
This publication has 100 references indexed in Scilit:
- Accelerated and enhanced effect of CCR5-transduced bone marrow neural stem cells on autoimmune encephalomyelitisActa Neuropathologica, 2012
- Human neural stem cells over-expressing choline acetyltransferase restore cognition in rat model of cognitive dysfunctionExperimental Neurology, 2012
- Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cellsNature, 2011
- The Science of Stroke: Mechanisms in Search of TreatmentsNeuron, 2010
- Pulmonary Passage is a Major Obstacle for Intravenous Stem Cell Delivery: The Pulmonary First-Pass EffectStem Cells and Development, 2009
- Hypoxic Preconditioning Enhances the Benefit of Cardiac Progenitor Cell Therapy for Treatment of Myocardial Infarction by Inducing CXCR4 ExpressionCirculation Research, 2009
- Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection, and with sparse CNS infiltrationNeuroscience Letters, 2008
- Maintenance of undifferentiated mouse embryonic stem cells in suspension by the serum‐ and feeder‐free defined culture conditionDevelopmental Dynamics, 2008
- Blocking TGF-β–Smad2/3 innate immune signaling mitigates Alzheimer-like pathologyNature Medicine, 2008
- Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosisNature, 2003